Literature DB >> 18032601

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.

Ralph J DeBerardinis1, Anthony Mancuso, Evgueni Daikhin, Ilana Nissim, Marc Yudkoff, Suzanne Wehrli, Craig B Thompson.   

Abstract

Tumor cell proliferation requires rapid synthesis of macromolecules including lipids, proteins, and nucleotides. Many tumor cells exhibit rapid glucose consumption, with most of the glucose-derived carbon being secreted as lactate despite abundant oxygen availability (the Warburg effect). Here, we used 13C NMR spectroscopy to examine the metabolism of glioblastoma cells exhibiting aerobic glycolysis. In these cells, the tricarboxylic acid (TCA) cycle was active but was characterized by an efflux of substrates for use in biosynthetic pathways, particularly fatty acid synthesis. The success of this synthetic activity depends on activation of pathways to generate reductive power (NADPH) and to restore oxaloacetate for continued TCA cycle function (anaplerosis). Surprisingly, both these needs were met by a high rate of glutamine metabolism. First, conversion of glutamine to lactate (glutaminolysis) was rapid enough to produce sufficient NADPH to support fatty acid synthesis. Second, despite substantial mitochondrial pyruvate metabolism, pyruvate carboxylation was suppressed, and anaplerotic oxaloacetate was derived from glutamine. Glutamine catabolism was accompanied by secretion of alanine and ammonia, such that most of the amino groups from glutamine were lost from the cell rather than incorporated into other molecules. These data demonstrate that transformed cells exhibit a high rate of glutamine consumption that cannot be explained by the nitrogen demand imposed by nucleotide synthesis or maintenance of nonessential amino acid pools. Rather, glutamine metabolism provides a carbon source that facilitates the cell's ability to use glucose-derived carbon and TCA cycle intermediates as biosynthetic precursors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032601      PMCID: PMC2148292          DOI: 10.1073/pnas.0709747104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Observations on the proliferation of human leucocytes cultured with phytohaemagglutinin.

Authors:  E H COOPER; P BARKHAN; A J HALE
Journal:  Br J Haematol       Date:  1963-01       Impact factor: 6.998

2.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

3.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

4.  The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid.

Authors:  H EAGLE; V I OYAMA; M LEVY; C L HORTON; R FLEISCHMAN
Journal:  J Biol Chem       Date:  1956-02       Impact factor: 5.157

5.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

6.  13C NMR studies of gluconeogenesis in rat liver cells: utilization of labeled glycerol by cells from euthyroid and hyperthyroid rats.

Authors:  S M Cohen; S Ogawa; R G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

7.  ATP citrate lyase inhibition can suppress tumor cell growth.

Authors:  Georgia Hatzivassiliou; Fangping Zhao; Daniel E Bauer; Charalambos Andreadis; Anthony N Shaw; Dashyant Dhanak; Sunil R Hingorani; David A Tuveson; Craig B Thompson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

8.  Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.

Authors:  D Haas-Kogan; N Shalev; M Wong; G Mills; G Yount; D Stokoe
Journal:  Curr Biol       Date:  1998-10-22       Impact factor: 10.834

9.  Early effects of phytohaemagglutinin on glucose metabolism of normal human lymphocytes.

Authors:  C J Hedeskov
Journal:  Biochem J       Date:  1968-11       Impact factor: 3.857

10.  Examination of primary metabolic pathways in a murine hybridoma with carbon-13 nuclear magnetic resonance spectroscopy.

Authors:  A Mancuso; S T Sharfstein; S N Tucker; D S Clark; H W Blanch
Journal:  Biotechnol Bioeng       Date:  1994-08-20       Impact factor: 4.530

View more
  1068 in total

1.  Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes.

Authors:  Sergio L Colombo; Miriam Palacios-Callender; Nanci Frakich; Joel De Leon; Christoph A Schmitt; Leanne Boorn; Nicola Davis; Salvador Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Role of monocarboxylate transporters in human cancers: state of the art.

Authors:  Céline Pinheiro; Adhemar Longatto-Filho; João Azevedo-Silva; Margarida Casal; Fernando C Schmitt; Fátima Baltazar
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

3.  A plant/fungal-type phosphoenolpyruvate carboxykinase located in the parasite mitochondrion ensures glucose-independent survival of Toxoplasma gondii.

Authors:  Richard Nitzsche; Özlem Günay-Esiyok; Maximilian Tischer; Vyacheslav Zagoriy; Nishith Gupta
Journal:  J Biol Chem       Date:  2017-07-18       Impact factor: 5.157

4.  SVD identifies transcript length distribution functions from DNA microarray data and reveals evolutionary forces globally affecting GBM metabolism.

Authors:  Nicolas M Bertagnolli; Justin A Drake; Jason M Tennessen; Orly Alter
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

Review 5.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

Review 6.  Understanding metabolism with flux analysis: From theory to application.

Authors:  Ziwei Dai; Jason W Locasale
Journal:  Metab Eng       Date:  2016-09-22       Impact factor: 9.783

Review 7.  Including the mitochondrial metabolism of L-lactate in cancer metabolic reprogramming.

Authors:  Lidia de Bari; Anna Atlante
Journal:  Cell Mol Life Sci       Date:  2018-05-04       Impact factor: 9.261

Review 8.  Metabolomics and Isotope Tracing.

Authors:  Cholsoon Jang; Li Chen; Joshua D Rabinowitz
Journal:  Cell       Date:  2018-05-03       Impact factor: 41.582

Review 9.  Pancreatic Cancer Metabolism: Molecular Mechanisms and Clinical Applications.

Authors:  Abdel Nasser Hosein; Muhammad Shaalan Beg
Journal:  Curr Oncol Rep       Date:  2018-05-11       Impact factor: 5.075

Review 10.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.